Tissue engineered vascular grafts - Preclinical aspects

Simple item page
dc.contributor.authorThomas, LV
dc.contributor.authorLekshmi, V
dc.contributor.authorNair, PD
dc.date.accessioned2017-03-10T03:29:03Z
dc.date.available2017-03-10T03:29:03Z
dc.date.issued2013
dc.description.abstractTissue engineering enables the development of fully biological vascular substitutes that restore, maintain and improve tissue function in a manner identical to natural host tissue. However the development of the appropriate preclinical evaluation techniques for the generation of fully functional tissue-engineered vascular graft (TEVG) is required to establish their safety for use in clinical trials and to test clinical effectiveness. This review gives an insight on the various preclinical studies performed in the area of tissue engineered vascular grafts highlighting the different strategies used with respect to cells and scaffolds, typical animal models used and the major in vivo evaluation studies that have been carried out. The review emphasizes the combined effort of engineers, biologists and clinicians which can take this clinical research to new heights of regenerative therapy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
dc.identifier.citation167 ,4;1091-1100en_US
dc.identifier.uri10.1016/j.ijcard.2012.09.069
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/10613
dc.publisherINTERNATIONAL JOURNAL OF CARDIOLOGY
dc.subjectCardiovascular System & Cardiology
dc.titleTissue engineered vascular grafts - Preclinical aspects
Files
Collections
Journal Articles